Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease.
Arthritis Rheumatol
; 73(1): 151-161, 2021 01.
Article
in En
| MEDLINE
| ID: mdl-32779863
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antirheumatic Agents
/
Interleukin 1 Receptor Antagonist Protein
/
Mucocutaneous Lymph Node Syndrome
Type of study:
Guideline
/
Prognostic_studies
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Arthritis Rheumatol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: